Skip to main content

Market Overview

Ovid Therapeutics Inc. (OVID)

4.37 -0.09 (-2.02%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2022
After-Hours
EPS:
REV:
2.53
208.383M



Q4 2021
Pre-Market
EPS:
REV:
-0.34
5.703M



Q3 2021
After-Hours
EPS:
REV:
-0.28
6.914M



Q2 2021
Pre-Market
EPS:
REV:
-0.41
0



Q1 2021
After-Hours
EPS:
REV:
-0.37
0
-0.14
1.29M
2.53
208.383M
1907.14%
16053.72%
Q4 2020
Pre-Market
EPS:
REV:
-0.35
0

-0.34
5.703M

Q3 2020
After-Hours
EPS:
REV:
-0.43
0
-0.36
80K
-0.28
6.914M
22.22%
8542.5%
Q2 2020
Pre-Market
EPS:
REV:
-0.34
0
-0.36
-0.41
0
-13.89%
Q1 2020
Pre-Market
EPS:
REV:
-0.46
0

-0.37
0

Q4 2019
Pre-Market
EPS:
REV:
-0.52
-0.41
-0.35
0
14.63%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!